Multiple pathways – no specific molecular target confirmed

The designation "Multiple pathways – no specific molecular target confirmed" refers to a category of therapeutic interventions where the exact molecular entity responsible for the drug's efficacy has not been definitively identified or where the drug acts on a broad spectrum of biological processes. This classification is often applied to drugs that exhibit pleiotropic effects, where the clinical benefit is derived from the modulation of multiple systems rather than the binding to a single receptor, enzyme, or ion channel (Nature Reviews Drug Discovery, 2018). Such agents may include complex natural products, certain traditional medicines, or legacy drugs developed before modern target-identification techniques were available (PubMed, PMID: 22329230). Because no single target is identified, these agents often present challenges in drug design, pharmacokinetic modeling, and the prediction of off-target effects (StatPearls, Drug Discovery and Development). Understanding the systemic impact of these drugs requires holistic approaches such as systems biology or phenotypic screening to map the broad changes in cellular behavior they induce (FDA, Copaxone Label).

Other names

Unknown mechanism of actionNon-specific molecular targetPleiotropic mechanismPhenotypic targetMulti-pathway modulation

The mechanism of action involves the simultaneous modulation of multiple biological pathways or systemic physiological responses, rather than a specific interaction with a single molecular target such as a receptor or enzyme (Nature Reviews Drug Discovery, 2018).